Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisuke Aoki

Showing results (271-280 of 479) with videos related to

Pageof 48
Sort By:
Acta Cytologica|March 29, 2002
Effectiveness of mass screening for endometrial cancerChikako Nakagawa-Okamura, Shinji Sato, Ichiro Tsuji, et al.
Gynecologic Oncology|September 8, 2004
A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinomaNao Suzuki, Daisuke Aoki, Shinji Oie, et al.
Reproductive Biology and Endocrinology : RB&E|January 16, 2016
Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasiaOsamu Inoue, Toshio Hamatani, Nobuyuki Susumu, et al.
Human Genome Variation|April 16, 2016
Characterization of the STK11 splicing variant as a normal splicing isomer in a patient with Peutz-Jeghers syndrome harboring genomic deletion of the STK11 geneKenta Masuda, Yusuke Kobayashi, Tokuhiro Kimura, et al.
Cancer Science|November 10, 2025
Prognostic Biomarker of Fertility-Preserving Hormonal Therapy Based on Multigene Panel Testing for Endometrial CancerTakuro Hirano, Kensuke Sakai, Takuma Yoshimura, et al.
Cancer Science|December 17, 2017
ADAM9 is over-expressed in human ovarian clear cell carcinomas and suppresses cisplatin-induced cell deathMari Ueno, Takayuki Shiomi, Satsuki Mochizuki, et al.
International Journal of Clinical Oncology|June 11, 2021
Incidence of germline variants in Lynch syndrome-related genes among Japanese endometrial cancer patients aged 40 years or youngerTakeshi Makabe, Wataru Yamagami, Akira Hirasawa, et al.
Anticancer Research|February 11, 2014
Application of FDG-PET in cervical cancer and endometrial cancer: utility and future prospectsYuya Nogami, Miho Iida, Kouji Banno, et al.
International Journal of Clinical Oncology|July 14, 2022
Efficacy and safety of olaparib maintenance monotherapy for Japanese patients with platinum-sensitive relapsed ovarian, fallopian tube, and primary peritoneal cancerTomoko Yoshihama, Yuka Kuroda, Tatsuyuki Chiyoda, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 29, 2021
A retrospective study for investigating the outcomes of endometrial cancer treated with radiotherapyKensuke Sakai, Wataru Yamagami, Hiroko Machida, et al.
Pageof 48

Showing results (271-280 of 479) with videos related to

Sort By:
Pageof 48
Acta Cytologica|March 29, 2002
Effectiveness of mass screening for endometrial cancerChikako Nakagawa-Okamura, Shinji Sato, Ichiro Tsuji, et al.
Gynecologic Oncology|September 8, 2004
A novel retinoid, 4-[3,5-bis (trimethylsilyl) benzamido] benzoic acid (TAC-101), induces apoptosis of human ovarian carcinoma cells and shows potential as a new antitumor agent for clear cell adenocarcinomaNao Suzuki, Daisuke Aoki, Shinji Oie, et al.
Reproductive Biology and Endocrinology : RB&E|January 16, 2016
Factors affecting pregnancy outcomes in young women treated with fertility-preserving therapy for well-differentiated endometrial cancer or atypical endometrial hyperplasiaOsamu Inoue, Toshio Hamatani, Nobuyuki Susumu, et al.
Human Genome Variation|April 16, 2016
Characterization of the STK11 splicing variant as a normal splicing isomer in a patient with Peutz-Jeghers syndrome harboring genomic deletion of the STK11 geneKenta Masuda, Yusuke Kobayashi, Tokuhiro Kimura, et al.
Cancer Science|November 10, 2025
Prognostic Biomarker of Fertility-Preserving Hormonal Therapy Based on Multigene Panel Testing for Endometrial CancerTakuro Hirano, Kensuke Sakai, Takuma Yoshimura, et al.
Cancer Science|December 17, 2017
ADAM9 is over-expressed in human ovarian clear cell carcinomas and suppresses cisplatin-induced cell deathMari Ueno, Takayuki Shiomi, Satsuki Mochizuki, et al.
International Journal of Clinical Oncology|June 11, 2021
Incidence of germline variants in Lynch syndrome-related genes among Japanese endometrial cancer patients aged 40 years or youngerTakeshi Makabe, Wataru Yamagami, Akira Hirasawa, et al.
Anticancer Research|February 11, 2014
Application of FDG-PET in cervical cancer and endometrial cancer: utility and future prospectsYuya Nogami, Miho Iida, Kouji Banno, et al.
International Journal of Clinical Oncology|July 14, 2022
Efficacy and safety of olaparib maintenance monotherapy for Japanese patients with platinum-sensitive relapsed ovarian, fallopian tube, and primary peritoneal cancerTomoko Yoshihama, Yuka Kuroda, Tatsuyuki Chiyoda, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|April 29, 2021
A retrospective study for investigating the outcomes of endometrial cancer treated with radiotherapyKensuke Sakai, Wataru Yamagami, Hiroko Machida, et al.
Pageof 48